The complex regulation of gene expression and cellular processes encompasses not only protein-coding transcripts but also a wide range of noncoding RNAs (ncRNAs). Recent research has highlighted the crucial roles of emerging ncRNA species, including PIWI-RNA, Xist RNA, small nuclear RNA (snRNA), small nucleolar RNA (snoRNA), and transfer RNA-derived small RNA (tsa-RNA). These ncRNAs are increasingly recognized as pivotal regulators of gene expression, influencing epigenetic modifications, transcriptional regulation, RNA processing, and the control of translation. Understanding the roles of these ncRNAs in various biological contexts has provided novel insights into fundamental cellular mechanisms and their dysregulation in disease states. Research has revealed that the misregulation of these ncRNAs is implicated in a broad spectrum of diseases, including cancer, neurodegenerative disorders, and metabolic syndromes. This deeper comprehension not only sheds light on the complex nature of cellular regulation but also highlights potential therapeutic targets for a variety of health conditions. Consequently, the elucidation of their molecular functions and regulatory networks presents promising avenues for the development of innovative therapeutic strategies. Harnessing the therapeutic potential of ncRNAs offers significant promise for precision medicine and the treatment of complex diseases. This chapter provides a comprehensive overview of the emerging landscape of the three emerging ncRNAs, including piRNAs, snoRNAs, and Xist RNAs, emphasizing their roles in health and disease and exploring the vast therapeutic opportunities they present. By delving into the mechanisms and applications of ncRNAs, we highlight their potential to revolutionize the treatment of diseases through targeted and precise molecular interventions.